Write a reviewFor vendors
♡
Home / Investors / Matthew Scholz

Matthew Scholz

Angel Investor · Seattle

About Matthew Scholz

Angel investor (Founder and Chief Executive Officer at Oisín Biotechnologies) based in Seattle, Washington. Focus areas include Health Care, Regenerative Medicine, Wellness. Past investments include Immusoft Corporation, Immusoft, Oisin BioTechnologies.

Investment focus

Sectors
Health CareRegenerative MedicineWellnessAndroidEngineeringAnti-AgingSoftwareBiotechnologyMarket ResearchProductivity SoftwareResearchGene TherapyMedicalMedia and EntertainmentPharmaceuticals

Portfolio

No portfolio companies recorded yet; Matthew Scholz reports 6 investments overall.

Similar investors

'- Kevin Petry -

Accelerator · Winter Park
AdvertisingHealth CareE-commerceAccounting+16
60Investments
—Exits

Aakash Patel

Venture Fund · New York City
Health CareCommercialTalent ManagementWearables+16
60Investments
—Exits

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Aaron Block

Angel Investor · New York City
Early Stage VentureAdvertisingHealth CareWomen FoundedEnterprise Software+16
60Investments
—Exits